Symbol Lookup

Friday March 24, 2017 3:53 PM ET. Data delayed 15 minutes.
0.20 (4.26%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
6:00AM ET on Wednesday Mar 01, 2017 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that Dirk van den Boom, Ph.D., has joined the Company's Board of Direct...

Sector Update: Health Care Stocks Easily Outpace Most Sectors
3:54PM ET on Thursday Feb 23, 2017 by MT Newswires
03:54 PM EST, 02/23/2017 (MT Newswires) -- Top Health Care Stocks JNJ +1.94% PFE +1.49% MRK +0.96% ABT +1.03% AMGN +0.63% Health care stocks continued to outpace most other sectors Thurday afternoon, with the NYSE Health Care Index climbing ...
Sector Update: Health Care
3:43PM ET on Thursday Feb 23, 2017 by MT Newswires
03:43 PM EST, 02/23/2017 (MT Newswires) -- Health care stocks continued to outpacing most other sectors Thursday afternoon, with the NYSE Health Care Index climbing nearly 1.1% while shares of health care companies in the S&P 500 were up almost 0...
Midday Update: Dow Extends Winning Streak on Strength in Oil
1:02PM ET on Thursday Feb 23, 2017 by MT Newswires
01:02 PM EST, 02/23/2017 (MT Newswires) -- The Dow Jones Industrial Average was trading higher for a tenth consecutive day as gains in oil futures and fiscal policy initiatives by the Trump administration drove the blue-chip index to another reco...
Correction: Dow Looks For Another Record-Setting Day as Oil, Mnuchin Buoys Wall Street
11:14AM ET on Thursday Feb 23, 2017 by MT Newswires
11:14 AM EST, 02/23/2017 (MT Newswires) -- (Corrects an item that was originally published at prior to the market open, at 9:18 a.m. E.T. on Feb. 23 - that gave an incorrect reason for why PTX shares were higher. The corrected version follows. No...

Company Information

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.


Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617


Chairman of the Board, President, Chief Executive OfficerRobert Jessup
DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
DirectorDirk van den Boom
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$13.5MBeta1.12
Revenue (TTM)$12.9MEPS$-5.12
Shares Out.2.9MBook Value$2.43
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)1.0
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-31.81%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample